在癌症发育和癌症抗药性中的MiR-223-3p:相同的硬币,不同的面孔
Davide Barbagallo1,2, Donatella Ponti3, Barbara Bassani4
1Department of Biomedical and Biotechnological Sciences, Section of Biology and Genetics "Giovanni Sichel", University of Catania, Via Santa Sofia 89, 95123 Catania, Italy.
International journal of molecular sciences
|August 10, 2024
概括
微RNA-223 (miR-223) 在癌症中起着双重作用,根据癌症类型,作为瘤基因或瘤抑制剂. 身体液体中miR-223的升高表明其作为癌症生物标志物的潜力.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 微RNAs (miRNAs) 是关键的转录后调节器,影响细胞功能和疾病.
- miR-223-3p (miR-223) 涉及血液形成,炎症和各种癌症类型,表现出取决于环境的瘤性或瘤抑制性活动.
- miR-223在癌症治疗敏感性或抗性的作用也取决于上下文.
研究的目的:
- 审查miR-223在各种人类癌症中的多方面的作用.
- 为了阐明miR-223在不同癌症类型中的双重致癌和致癌抑制功能.
- 探索miR-223作为瘤学诊断和预后生物标志物的潜力.
主要方法:
- 关于研究癌症中的miR-223的综合文献综述.
- 在不同恶性瘤中分析miR-223的表达模式和功能作用.
- 在瘤和瘤抑制的背景下,确定关键的miR-223目标,如NLRP3和FBXW7.
主要成果:
- miR-223在乳腺癌,非小细胞肺癌和质母细胞瘤中表现出瘤抑制作用.
- 在结直肠,卵巢,胰腺癌和急性淋巴细胞白血病中,miR-223的致癌作用占主导地位.
- miR-223在前列腺癌和血液性恶性瘤中发挥了可变的作用,其中NLRP3和FBXW7被确定为关键标.
- 在许多分析的癌症中,在生物流体和细胞外囊泡中观察到miR-223水平的增加.
结论:
- miR-223在癌症进展和抑制方面发挥着特定环境的双重作用.
- 生物流体中miR-223的表达水平表明它有可能成为癌症诊断和预后的有价值生物标志物.
- 了解miR-223的复杂作用对于开发向癌症疗法至关重要.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


